212 related articles for article (PubMed ID: 26119800)
21. Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Massa AF; Varela P; Osório-Ferreira E; Nora M; Couceiro A; Baptista A
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):821-2. PubMed ID: 24588974
[No Abstract] [Full Text] [Related]
22. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
Reguiaï Z; Tchen T; Perceau G; Bernard P
Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
[TBL] [Abstract][Full Text] [Related]
23. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
Czernik A; Bystryn JC
Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases.
Daniel BS; Murrell DF
G Ital Dermatol Venereol; 2012 Jun; 147(3):259-67. PubMed ID: 22648327
[TBL] [Abstract][Full Text] [Related]
25. Refractory bullous pemphigoid with fatal outcome in a young patient.
Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
[No Abstract] [Full Text] [Related]
26. Coexistence case of bullous pemphigoid and pemphigus foliaceus.
Tsujiwaki M; Abe R; Nomura Y; Nishimura M; Hoshina D; Shinkuma S; Natsuga K; Ujiie H; Arita K; Shimizu H
Eur J Dermatol; 2013; 23(4):552-3. PubMed ID: 24001742
[No Abstract] [Full Text] [Related]
27. Trends in mortality and morbidity in patients with bullous pemphigoid before and after approval of intravenous immunoglobulin in Japan: an interrupted time-series analysis.
Miyachi H; Konishi T; Hashimoto Y; Matsui H; Fushimi K; Inozume T; Matsue H; Yasunaga H
Clin Exp Dermatol; 2023 Jun; 48(6):667-673. PubMed ID: 36891872
[TBL] [Abstract][Full Text] [Related]
28. Severe bullous pemphigoid in an infant--successful treatment with rituximab.
Schulze J; Bader P; Henke U; Rose MA; Zielen S
Pediatr Dermatol; 2008; 25(4):462-5. PubMed ID: 18789089
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
[TBL] [Abstract][Full Text] [Related]
30. Bullous scabies failing to respond to glucocorticoids, immunoglobulin, and cyclophosphamide.
Chen MC; Luo DQ
Int J Dermatol; 2014 Apr; 53(4):e265-6. PubMed ID: 24134198
[No Abstract] [Full Text] [Related]
31. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
[TBL] [Abstract][Full Text] [Related]
32. Childhood lichen planus pemphigoides: report of two cases treated successfully with systemic glucocorticoids and dapsone.
Goldscheider I; Herzinger T; Varga R; Eming R; Ruzicka T; Flaig MJ; Sárdy M
Pediatr Dermatol; 2014; 31(6):751-3. PubMed ID: 24138413
[TBL] [Abstract][Full Text] [Related]
33. Bullous pemphigoid in adolescence.
Patsatsi A; Kyriakou A; Werth VP
Pediatr Dermatol; 2019 Mar; 36(2):184-188. PubMed ID: 30569520
[TBL] [Abstract][Full Text] [Related]
34. Development of pemphigoid nodularis after remission of bullous lesions.
Hattori M; Shimizu A; Ishikawa O
Clin Exp Dermatol; 2019 Mar; 44(2):e1-e2. PubMed ID: 30242789
[No Abstract] [Full Text] [Related]
35. Bullous Pemphigoid in Three Paediatric Patients in Finland.
Pankakoski A; Panelius J; Salava A; Kluger N
Acta Derm Venereol; 2020 Mar; 100(6):adv00086. PubMed ID: 32157316
[No Abstract] [Full Text] [Related]
36. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis.
Nguyen T; Alraqum E; Razzaque Ahmed A
Int Immunopharmacol; 2015 May; 26(1):1-3. PubMed ID: 25765353
[TBL] [Abstract][Full Text] [Related]
37. Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous Immunoglobulin.
Juhász M; Rogge M; Chen M; Czernik A; Jung Kim S; Geller L
Pediatr Dermatol; 2017 Jan; 34(1):e54-e56. PubMed ID: 27778386
[TBL] [Abstract][Full Text] [Related]
38. Bullous pemphigoid complicated by necrotising fasciitis successfully treated with systemic corticosteroids and antibiotics in combination with i.v. immunoglobulin.
Noguchi E; Kamiya K; Maekawa T; Komine M; Murata S; Ohtsuki M
Australas J Dermatol; 2018 Nov; 59(4):e313-e314. PubMed ID: 29797437
[No Abstract] [Full Text] [Related]
39. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
Gürcan HM; Ahmed AR
Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
